948894-79-9

Upstream product

• 948894-78-8 benzyloxy-5-[2-{[1-(2-benzyloxy-ethyl)-4-hydroxy-piperidin-4-ylmethyl]-amino}-(1R)-(tert-butyl-dimethyl-silanyloxy)-ethyl]-1H-quinolin-2-one 
• 93609-84-8 5-acetyl-8-benzyloxy-1H-quinolin-2-one 
• 41979-39-9 4-piperidone hydrochloride 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 1462-37-9 bromoethyl-2-benzyl ether 
• 948894-77-7 4-aminomethyl-1-(2-benzyloxy-ethyl)-piperidin-4-ol 
• 948894-76-6 1-(2-benzyloxy-ethyl)-piperidin-4-one 
• 100331-89-3 8-benzyloxy-5-(2-bromoacetyl)-1H-quinolin-2-one 
• 530084-74-3 (R)-8-(benzyloxy)-5-(2-bromo-1-((tert-butyldimethylsilyl)oxy)ethyl)quinolin-2(1H)-one 
• 530084-79-8 8-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]quinolin-2(1H)-one 

Relevant academic research and scientific papers

PHENETHANOLAMINE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS

The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta2 adrenoreceptor agonists.